Literature DB >> 22932266

Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.

Chuyao Zhang1, Chao Wang, Weiwei Feng.   

Abstract

OBJECTIVE: To identify the clinicopathological risk factors for pelvic lymph node (PLN) metastasis and to evaluate the predictive significance of these factors for lymphadenectomy in clinical early-stage endometrioid endometrial adenocarcinoma (EEA).
METHODS: Six hundred and twenty-one patients with clinical early-stage EEA (tumor confined to uterus, diagnosed preoperatively or intraoperatively) who underwent hysterectomy plus bilateral salpingo-oophorectomy plus pelvic and/or para-aortic lymphadenectomy between 1989 and 2006 in the Obstetrics and Gynecology Hospital of Fudan University were retrieved. The predictive value of the risk factors for PLN metastasis was analyzed.
RESULTS: The positive PLN metastasis rate was 3.9%. The 5-year disease-related mortality rate in the positive PLN metastasis group was 25%, whereas the rate in the negative group was 0.8%. The positive PLN metastasis rates were higher in patients with higher-grade tumors, deep myometrial invasion, cervical stromal involvement, and lymphovascular space involvement (LVSI). The sensitivity and specificity of old age (≥ 60 years), grade 3, cancer deep myometrial invasion, cervical stromal involvement, and LVSI in predicting the PLN metastasis were 25.0%, 41.7%, 70.8%, 20.8%, and 41.7%; and 79.1%, 88.4%, 85.6%, 95.6%, and 94.5%, respectively. The multivariate analysis revealed that the deep myometrial invasion and LVSI were independent risk factors for lymph node metastasis. Combined with these 2 factors as the diagnostic criteria, the negative predictive value and specificity were 97.3% and 89.1%, respectively.
CONCLUSION: The patients with clinical early-stage EEA with PLN metastasis showed worse prognoses, although the metastasis rate was low. The deep myometrial invasion and LVSI combination were superior predictive criteria for the PLN metastasis. An accurate evaluation of these factors, both preoperatively or intraoperatively, will be beneficial to predict PLN metastasis and guide the operation.

Entities:  

Mesh:

Year:  2012        PMID: 22932266     DOI: 10.1097/IGC.0b013e318269f68e

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

1.  Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.

Authors:  Ricardo dos Reis; Jennifer K Burzawa; Audrey T Tsunoda; Masayoshi Hosaka; Michael Frumovitz; Shannon N Westin; Mark F Munsell; Pedro T Ramirez
Journal:  Int J Gynecol Cancer       Date:  2015-09       Impact factor: 3.437

Review 2.  Lymphovascular Space Invasion as a Risk Factor in Early Endometrial Cancer.

Authors:  Azmat H Sadozye; Rosie L Harrand; Nick S Reed
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

3.  Median Survival Time of Endometrial Cancer Patients with Lymphovascular Invasion at the Hospital Universiti Sains Malaysia.

Authors:  Wan Adnan Wan Nor Asyikeen; Ab Hamid Siti-Azrin; Nur Asyilla Che Jalil; Anani Aila Mat Zin; Nor Hayati Othman
Journal:  Malays J Med Sci       Date:  2016-12-07

4.  Prediction of staging with preoperative parameters and frozen/section in patients with a preoperative diagnosis of grade 1 endometrioid tumor in endometrial cancer.

Authors:  Alper Karalok; Işın Ureyen; Yıldız Reis; Ozge Oktay; Taner Turan; Nurettin Boran; Dilek Bülbül; Gökhan Tulunay; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-01-30

5.  Prediction of lymph node metastasis in patients with apparent early endometrial cancer.

Authors:  Joo-Hyuk Son; Tae-Wook Kong; Su Hyun Kim; Jiheum Paek; Suk-Joon Chang; Eun Ju Lee; Hee-Sug Ryu
Journal:  Obstet Gynecol Sci       Date:  2015-09-22

6.  Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.

Authors:  Dou Dou Liu; Jianfang Li; Xiaomao Li; Liangjun Xie; Luping Qin; Fangyu Peng; Mu Hua Cheng
Journal:  J Gynecol Oncol       Date:  2019-11       Impact factor: 4.401

7.  Association of Myometrial Invasion With Lymphovascular Space Invasion, Lymph Node Metastasis, Recurrence, and Overall Survival in Endometrial Cancer: A Meta-Analysis of 79 Studies With 68,870 Patients.

Authors:  Jianzhang Wang; Ping Xu; Xueying Yang; Qin Yu; Xinxin Xu; Gen Zou; Xinmei Zhang
Journal:  Front Oncol       Date:  2021-10-21       Impact factor: 6.244

8.  Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.

Authors:  Vakkas Korkmaz; Mehmet Mutlu Meydanli; Ibrahim Yalçın; Mustafa Erkan Sarı; Hanifi Sahin; Eda Kocaman; Ali Haberal; Polat Dursun; Tayfun Güngör; Ali Ayhan
Journal:  J Gynecol Oncol       Date:  2017-11       Impact factor: 4.401

9.  Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?

Authors:  Menghan Zhu; Nan Jia; Feifei Huang; Xiaoxia Liu; Yuqing Zhao; Xiang Tao; Wei Jiang; Qin Li; Weiwei Feng
Journal:  BMC Cancer       Date:  2017-10-23       Impact factor: 4.430

10.  Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

Authors:  Anna L Beavis; Ting-Tai Yen; Rebecca L Stone; Stephanie L Wethington; Caitlin Carr; Ji Son; Laura Chambers; Chad M Michener; Stephanie Ricci; Wesley C Burkett; Debra L Richardson; Allison-Stuart Staley; Susie Ahn; Paola A Gehrig; Diogo Torres; Sean C Dowdy; Mackenzie W Sullivan; Susan C Modesitt; Catherine Watson; Ashely Veade; Jessie Ehrisman; Laura Havrilesky; Angeles Alvarez Secord; Amy Loreen; Kaitlyn Griffin; Amanda Jackson; Akila N Viswanathan; Leah R Jager; Amanda N Fader
Journal:  Gynecol Oncol       Date:  2020-01-14       Impact factor: 5.482

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.